Volatile Biomarkers in Breath Associated With Liver Cirrhosis - Comparisons of Pre- and Post-liver Transplant Breath Samples

EBioMedicine

Volumn 2, Issue 9, 2015, Pages 1243-1250

  Fernandez del Rio R ^a   O'Hara, M E ^a   Holt, A ^b   Pemberton, P ^b   Shah, T ^b   Whitehouse, T ^b   Mayhew, C A ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Breath analysis; Cirrhosis; Diagnosis limonene; Liver transplant; PTR MS; Volatile organic compounds

Indexed keywords

2 BUTANONE; BIOLOGICAL MARKER; CARBON DISULFIDE; LIMONENE; METHANOL; 2-PENTANONE; ALKANONE; CYCLOHEXENE DERIVATIVE; TERPENE;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; AUTOIMMUNE LIVER DISEASE; BREATH ANALYSIS; CAPNOMETER; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG DETERMINATION; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; LIVER DISEASE; LIVER GRAFT; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; AGED; COMPARATIVE STUDY; LIVER TRANSPLANTATION; PROCEDURES; VOLATILIZATION;

ADULT; AGED; BIOMARKERS; BREATH TESTS; CYCLOHEXENES; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; METHANOL; MIDDLE AGED; PENTANONES; ROC CURVE; TERPENES; VOLATILIZATION;

EID: 84953719251     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2015.07.027     Document Type: Article

References (50)

1. Agarwal B., Petersson F., Jurschik S., Sulzer P., Jordan A., Mark T.D., et al. Use of proton transfer reaction time-of-flight mass spectrometry for the analytical detection of illicit and controlled prescription drugs at room temperature via direct headspace sampling. Anal. Bioanal. Chem. 2011, 400(8):2631-2639.
2. Beauchamp J. Inhaled today, not gone tomorrow: pharmacokinetics and environmental exposure of volatiles in exhaled breath. J. Breath Res. 2011, 5(3):037103. (Epub 2011/06/10).
3. Beauchamp J., Herbig J., Gutmann R., Hansel A. On the use of Tedlar(R) bags for breath-gas sampling and analysis. J Breath Res 2008, 2(4):046001. Epub 2008/12/01. 10.1088/1752-7155/2/4/046001.
4. Boston R.C., Schnall M.D., Englander S.A., Landis J.R., Moate P.J. Estimation of the content of fat and parenchyma in breast tissue using MRI T1 histograms and phantoms. Magn. Reson. Imaging 2005, 23(4):591-599. (Epub 2005/05/28).
5. Broadhurst D.I., Kell D.B. Statistical strategies for avoiding false discoveries in metabolomics and related experiments. Metabolomics 2006, 2(4):171-196.
6. Brown P., Watts P., Mark T.D., Mayhew C.A. Proton transfer reaction mass spectrometry investigations on the effects of reduced electric field and reagent ion internal energy on product ion branching ratios for a series of saturated alcohols. Int. J. Mass Spectrom. 2010, 294(2-3):103-111.
7. Castera L., Lik Yuen Chan H., Arrese M., Afdhal N., Bedossa P., Friedrich-Rust M., Han K.H., Pinzani M. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J. Hepatol. 2015, 63:237-264.
8. Dadamio J., Van den Velde S., Laleman W., Van Hee P., Coucke W., Nevens F., et al. Breath biomarkers of liver cirrhosis. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2012, 905:17-22. (Epub 2012/08/28).
9. Davies S. CMO Annual Report: Volume One, 2011 'On The State of the Public's Health' 2012, Department of Health, (Available from: http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/health/2012/11/cmo-annual-report/).
10. de Gouw J.A., Middlebrook A.M., Warneke C., Ahmadov R., Atlas E.L., Bahreini R., et al. Organic aerosol formation downwind from the deepwater horizon oil spill. Science 2011, 331(6022):1295-1299.
11. de Lacy Costello B., Amann A., Al-Kateb H., Flynn C., Filipiak W., Khalid T., et al. A review of the volatiles from the healthy human body. J. Breath Res. 2014, 8(1):014001. (Epub 2014/01/15).
12. Ellis A.M., Mayhew C.A. Proton Transfer Reaction Mass Spectrometry Principles and Applications 2014, John Wiley & Sons Ltd., UK.
13. Falk A., Gullstrand E., Lof A., Wigaeus-Hjelm E. Liquid/air partition coefficients of four terpenes. Br. J. Ind. Med. 1990, 47(1):62-64. (Epub 1990/01/01).
14. Filipiak W., Sponring A., Filipiak A., Ager C., Schubert J., Miekisch W., et al. TD-GC-MS analysis of volatile metabolites of human lung cancer and normal cells in vitro. Cancer Epidemiol. Biomark. Prev. 2010, 19(1):182-195.
15. Friedman M.I., Preti G., Deems R.O., Friedman L.S., Munoz S.J., Maddrey W.C. Limonene in expired lung air of patients with liver-disease. Dig. Dis. Sci. 1994, 39(8):1672-1676.
16. Frye R.F., Zgheib N.K., Matzke G.R., Chaves-Gnecco D., Rabinovitz M., Shaikh O.S., et al. Liver disease selectively modulates cytochrome P450-mediated metabolism. Clin. Pharmacol. Ther. 2006, 80(3):235-245. (Epub 2006/09/06).
17. Griffin S., Wyllie S.G., Markham J. Determination of octanol-water partition coefficient for terpenoids using reversed-phase high-performance liquid chromatography. J. Chromatogr. A 1999, 864(2):221-228.
18. Hanouneh I.A., Zein N.N., Cikach F., Dababneh L., Grove D., Alkhouri N., et al. The breathprints in patients with liver disease identify novel breath biomarkers in alcoholic hepatitis. Clin. Gastroenterol. Hepatol. 2014, 12(3):516-523.
19. Jurschik S., Agarwal B., Kassebacher T., Sulzer P., Mayhew C.A., Mark T.D. Rapid and facile detection of four date rape drugs in different beverages utilizing proton transfer reaction mass spectrometry (PTR-MS). J. Mass Spectrom. 2012, 47(9):1092-1097.
20. Khalid T.Y., Costello B., Ewen R., White P., Stevens S., Gordon F., et al. Breath volatile analysis from patients diagnosed with harmful drinking, cirrhosis and hepatic encephalopathy: a pilot study. Metabolomics 2013, 9(5):938-948.
21. Khalid T., Richardson P., Probert C.S. The liver breath! breath volatile organic compounds for the diagnosis of liver disease. Clin. Gastroenterol. Hepatol. 2014, 12(3):524-526.
22. King J., Mochalski P., Kupferthaler A., Unterkofler K., Koc H., Filipiak W., et al. Dynamic profiles of volatile organic compounds in exhaled breath as determined by a coupled PTR-MS/GC-MS study. Physiol. Meas. 2010, 31(9):1169-1184.
23. Kwak J., Preti G. Volatile disease biomarkers in breath: a critique. Curr. Pharm. Biotechnol. 2011, 12(7):1067-1074.
24. Lindinger W., Taucher J., Jordan A., Hansel A., Vogel W. Endogenous production of methanol after the consumption of fruit. Alcohol. Clin. Exp. Res. 1997, 21(5):939-943.
25. Lindinger W., Hansel A., Jordan A. On-line monitoring of volatile organic compounds at pptv levels by means of proton-transfer-reaction mass spectrometry (PTR-MS) - medical applications, food control and environmental research. Int. J. Mass Spectrom. 1998, 173(3):191-241.
26. Miller J.A., Lang J.E., Ley M., Nagle R., Hsu C.H., Thompson P.A., et al. Human breast tissue disposition and bioactivity of limonene in women with early-stage breast cancer. Cancer Prev. Res. (Phila.) 2013, 6(6):577-584. (Epub 2013/04/05).
27. Millonig G., Praun S., Netzer M., Baumgartner C., Dornauer A., Mueller S., et al. Non-invasive diagnosis of liver diseases by breath analysis using an optimized ion-molecule reactionmass spectrometry approach: a pilot study. Biomarkers 2010, 15(4):297-306.
28. Miyazawa M., Shindo M., Shimada T. Metabolism of (+)- and (-)-limonenes to respective carveols and perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes. Drug Metab. Dispos. 2002, 30(5):602-607.
29. Mochalski P., King J., Klieber M., Unterkofler K., Hinterhuber H., Baumann M., et al. Blood and breath levels of selected volatile organic compounds in healthy volunteers. Analyst 2013, 138(7):2134-2145.
30. Morisco F., Aprea E., Lembo V., Fogliano V., Vitaglione P., Mazzone G., et al. Rapid "breath-print" of liver cirrhosis by proton transfer reaction time-of-flight mass spectrometry. a pilot study. PloS One 2013, 8(4).
31. O'Hara M.E., O'Hehir S., Green S., Mayhew C.A. Development of a protocol to measure volatile organic compounds in human breath: a comparison of rebreathing and on-line single exhalations using proton transfer reaction mass spectrometry. Physiol. Meas. 2008, 29(3):309-330.
32. O'Hara M.E., Clutton-Brock T.H., Green S., O'Hehir S., Mayhew C.A. Mass spectrometric investigations to obtain the first direct comparisons of endogenous breath and blood volatile organic compound concentrations in healthy volunteers. Int. J. Mass Spectrom. 2009, 281(1-2):92-96.
33. O'Hara M.E., Clutton-Brock T.H., Green S., Mayhew C.A. Endogenous volatile organic compounds in breath and blood of healthy volunteers: examining breath analysis as a surrogate for blood measurements. J. Breath Res. 2009, 3(2).
34. Pleil J.D., Stiegel M.A., Risby T.H. Clinical breath analysis: discriminating between human endogenous compounds and exogenous (environmental) chemical confounders. J. Breath Res. 2013, 7(1):017107. (Epub 2013/03/01).
35. Ransohoff D.F. Bias as a threat to the validity of cancer molecular-marker research. Nat. Rev. Cancer 2005, 5(2):142-149. (Epub 2005/02/03).
36. Sangster J. Octanol-water partition-coefficients of simple organic-compounds. J. Phys. Chem. Ref. Data 1989, 18(3):1111-1229.
37. 2-controlled sampling of alveolar gas in mechanically ventilated patients. J. Appl. Physiol. 2001, 90(2):486-492.
38. Schubert J.K., Miekisch W., Birken T., Geiger K., Noldge-Schomburg G.F.E. Impact of inspired substance concentrations on the results of breath analysis in mechanically ventilated patients. Biomarkers 2005, 10(2-3):138-152.
39. Sehnert S.S., Jiang L., Burdick J.F., Risby T.H. Breath biomarkers for detection of human liver diseases: preliminary study. Biomarkers 2002, 7(2):174-187.
40. Shimamoto C., Hirata I., Katsu K. Breath and blood ammonia in liver cirrhosis. Hepato-Gastroenterology 2000, 47(32):443-445.
41. Siragusa R.J., Cerda J.J., Baig M.M., Burgin C.W., Robbins F.L. Methanol production from the degradation of pectin by human colonic bacteria. Am. J. Clin. Nutr. 1988, 47(5):848-851.
42. Skrzydlewska E. Toxicological and metabolic consequences of methanol poisoning. Toxicol. Mech. Methods 2003, 13(4):277-293.
43. Solga S.F., Alkhuraishe A., Cope K., Tabesh A., Clark J.M., Torbenson M., et al. Breath biomarkers and non-alcoholic fatty liver disease: preliminary observations. Biomarkers 2006, 11(2):174-183.
44. Spanel P., Dryahina K., Smith D. A quantitative study of the influence of inhaled compounds on their concentrations in exhaled breath. J. Breath Res. 2013, 7(1):017106. (Epub 2013/03/01).
45. Stegink L.D., Filer L.J., Bell E.F., Ziegler E.E., Tephly T.R. Effect of repeated ingestion of aspartame-sweetened beverage on plasma amino acid, blood methanol, and blood formate concentrations in normal adults. Metabolism 1989, 38(4):357-363.
46. Tangerman A., Meuwesearends M.T., Vantongeren J.H.M. A new sensitive assay for measuring volatile sulfur-compounds in human breath by Tenax trapping and gas-chromatography and its application in liver-cirrhosis. Clin. Chim. Acta 1983, 130(1):103-110.
47. Van den Velde S., Nevens F., Van Hee P., van Steenberghe D., Quirynen M. GC-MS analysis of breath odor compounds in liver patients. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2008, 875(2):344-348.
48. Verdam F.J., Dallinga J.W., Driessen A., de Jonge C., Moonen E.J., van Berkel J.B., et al. Non-alcoholic steatohepatitis: a non-invasive diagnosis by analysis of exhaled breath. J. Hepatol. 2013, 58(3):543-548. (Epub 2012/11/13).
49. Vollnberg B.O., Gunther R., Buch S., Schafmayer C., Braun F., Hinrichsen H.M., et al. Metabolomic analysis of breath air and tongue swabs using gas chromatography/mass spectrometry identifies novel metabolic markers of hepatic encephalopathy. Gastroenterology 2009, 136(5):A829-A830.
50. Williams R., Aspinall R., Bellis M., Camps-Walsh G., Cramp M., Dhawan A., et al. Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis. Lancet 2014, 384(9958):1953-1997. (Epub 2014/12/01).